| The Partnering for Cures program offers something for everyone. The major components are:
This year's Partnering for Cures program will feature 16 panels addressing mission-critical issues in the life sciences – from innovation to regulation, from drug repositioning to de-risking investments, and from translational research to data networks. Instead of traditional keynote speakers, our panels feature interactive discussions and occasional one-on-one interviews with leading biomedical research innovators. Speakers include philanthropists, industry executives, patient advocates, nonprofit foundations, and academic and industry scientists engaged in some of the most constructively disruptive approaches to research.
Partnering for Cures features up to 30 presentations from innovative collaborative programs working to reduce the time it takes to move new medical solutions from discovery to patients. Learn about new approaches to commercialization, data sharing, financing early-stage research, asset repurposing, and more. Each 25-mintute presentation allows these novel, cross-sector partnerships to engage potential investors, partners, and/or collaborators in moving their existing initiatives forward and amplifying the impact of their approach.
Partnering for Cures offers its attendees one-on-one pro-bono consultations with leading experts from the medical research industry in areas such as strategic planning, deal structuring, and attracting capital. Those who wish to participate have the opportunity to choose a specialist to provide them individual, tailored analysis based on the attendee's specific needs.
Therapeutic Affinity RoundtablesAttendees are welcome to partake in focused, informal networking opportunities through which they can engage with leaders in their specific field. Please stay tuned for more details.
We'll continue to update this page as panels and presentations are assigned to time slots. Stay tuned for details. |
